Clene Inc. Files 8-K
Ticker: CLNN · Form: 8-K · Filed: Dec 3, 2025 · CIK: 1822791
| Field | Detail |
|---|---|
| Company | Clene Inc. (CLNN) |
| Form Type | 8-K |
| Filed Date | Dec 3, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001, $230.00 |
| Sentiment | neutral |
Sentiment: neutral
Topics: filing, financials
TL;DR
Clene Inc. filed a routine 8-K on 12/3/25. No major news.
AI Summary
Clene Inc. filed an 8-K on December 3, 2025, reporting other events and financial statements. The company, formerly known as Chelsea Worldwide Inc. until August 27, 2020, is incorporated in Delaware and headquartered in Salt Lake City, Utah. The filing does not disclose specific financial figures or material events beyond its routine reporting nature.
Why It Matters
This 8-K filing from Clene Inc. serves as a routine update, indicating the company has submitted required financial statements and reported on other events as of December 3, 2025.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for routine reporting and does not contain information about significant new risks or material adverse events.
Key Players & Entities
- Clene Inc. (company) — Registrant
- Chelsea Worldwide Inc. (company) — Former company name
- Delaware (jurisdiction) — State of incorporation
- Salt Lake City, Utah (location) — Principal executive offices
- December 3, 2025 (date) — Date of report
FAQ
What is the primary purpose of this 8-K filing for Clene Inc.?
The primary purpose of this 8-K filing for Clene Inc. is to report on 'Other Events' and 'Financial Statements and Exhibits' as of December 3, 2025.
When was Clene Inc. formerly known by another name?
Clene Inc. was formerly known as Chelsea Worldwide Inc. until August 27, 2020.
In which state is Clene Inc. incorporated?
Clene Inc. is incorporated in Delaware.
What is the business address of Clene Inc.?
The business address of Clene Inc. is 6550 South Millrock Drive, Suite G50, Salt Lake City, Utah 84121.
What is the SEC file number for Clene Inc.?
The SEC file number for Clene Inc. is 001-39834.
Filing Stats: 465 words · 2 min read · ~2 pages · Grade level 11.2 · Accepted 2025-12-03 08:01:19
Key Financial Figures
- $0.0001 — nge on which registered Common Stock, $0.0001 par value CLNN The Nasdaq Capital M
- $230.00 — rtieth of one share of Common Stock for $230.00 per share CLNNW The Nasdaq Capital
Filing Documents
- clnn20251203_8k.htm (8-K) — 28KB
- ex_894886.htm (EX-99.1) — 33KB
- 0001437749-25-036712.txt ( ) — 218KB
- clnn-20251203.xsd (EX-101.SCH) — 4KB
- clnn-20251203_def.xml (EX-101.DEF) — 14KB
- clnn-20251203_lab.xml (EX-101.LAB) — 18KB
- clnn-20251203_pre.xml (EX-101.PRE) — 14KB
- clnn20251203_8k_htm.xml (XML) — 5KB
01 Other Events
Item 8.01 Other Events. On December 3, 2025, Clene Inc. issued a press release announcing statistically significant amyotrophic lateral sclerosis ("ALS") biomarker results supporting an accelerated approval pathway for CNM-Au8. A copy of the press release is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit Number Exhibit Description 99.1 Press release, dated December 3, 2025, announcing statistically significant ALS biomarker results supporting accelerated approval pathway for CNM-Au8. 104 Cover Page Interactive Data File (formatted as Inline XBRL). 1
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized. CLENE INC. Date: December 3, 2025 By: /s/ Robert Etherington Robert Etherington President and Chief Executive Officer 2